- Home
- ALLE vs SNN Comparison
ALLE vs SNN Comparison
Compare ALLE & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALLE | SNN |
|---|---|---|
| Founded | 2013 | 1856 |
| Country | Ireland | United Kingdom |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.9B | 14.0B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | ALLE | SNN |
|---|---|---|
| Price | $159.24 | $33.44 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 9 | 4 |
| Target Price | ★ $172.22 | $32.83 |
| AVG Volume (30 Days) | ★ 787.1K | 476.9K |
| Earning Date | 10-23-2025 | 03-02-2026 |
| Dividend Yield | 1.28% | ★ 2.19% |
| EPS Growth | 13.70 | ★ 59.91 |
| EPS | ★ 7.39 | 0.56 |
| Revenue | $3,979,700,000.00 | ★ $5,944,000,000.00 |
| Revenue This Year | $10.07 | $7.78 |
| Revenue Next Year | $6.53 | $5.13 |
| P/E Ratio | ★ $21.53 | $29.10 |
| Revenue Growth | ★ 6.87 | 5.35 |
| 52 Week Low | $116.57 | $23.69 |
| 52 Week High | $180.68 | $38.79 |
Technical Indicators
Market Signals| Indicator | ALLE | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 35.06 | 48.01 |
| Support Level | $163.27 | $32.68 |
| Resistance Level | $167.01 | $33.56 |
| Average True Range (ATR) | 3.10 | 0.41 |
| MACD | 0.01 | 0.14 |
| Stochastic Oscillator | 2.11 | 78.51 |
Price Performance
Historical ComparisonAbout ALLE Allegion plc
Allegion is a global security products company with a portfolio of leading brands such as Schlage, Von Duprin, and LCN. The Ireland-domiciled company was created via a spinoff transaction from Ingersoll-Rand in December 2013. In fiscal 2024, Allegion generated over 75% of sales in the United States. The company primarily competes with Sweden-based Assa Abloy, Switzerland-based Dormakaba, and US-based Fortune Brands Innovations.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.